# US 2022/0031919 A1 · Power source selection for a fully implantable lvad system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031919 A1
- Document ID: US20220031919A1
- Status: Published application
- Kind: A1
- Application number: 16/944,564
- Filed: 2020-07-31
- Published: 2022-02-03
- Earliest claimed: 2020-07-31
- Assignees: Medtronic, Inc.
- Applicants: Medtronic, Inc.
- Inventors: Eric A. SCHILLING; Jacob A. ROE; Joel B. ARTMANN; Jason C. Lee; Jonathan P. ROBERTS; David J. PEICHEL
- Web page: https://patentgrep.com/patent/US20220031919A1

## CPC

- A61M 60/178: drawing blood from a ventricle and returning the blood to the arterial system via a cannula external to the ventricle, e.g. left or right ventricular assist devices
- A61M 60/50: Details relating to control
- A61M 60/148: in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices
- A61M 60/232: Centrifugal pumps
- A61M 60/237: the blood flow through the rotating member having mainly axial components, e.g. axial flow pumps
- A61M 60/508: Electronic control means, e.g. for feedback regulation
- A61M 60/871: Energy supply devices; Converters therefor
- A61M 60/873: specially adapted for wireless or transcutaneous energy transfer [TET], e.g. inductive charging
- A61M 60/876: Implantable batteries
- A61M 2205/3365: Rotational speed
- A61M 2205/52: with memories providing a history of measured variating parameters of apparatus or patient
- A61M 2205/8206: battery-operated
- A61M 2205/8237: Charging means
- A61M 2205/8243: by induction
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A method of managing multiple power sources for an implantable blood pump includes operating the implantable blood pump with both power from an internal battery, the internal battery being disposed within an implantable controller and in communication with the implantable blood pump, and with transcutaneous energy transfer system (TETS) power in communication with the implantable blood pump, if TETS power is available.

## Claims

### Claim 1

A method of managing multiple power sources for an implantable blood pump, comprising:
operating the implantable blood pump with both power from an internal battery, the internal battery being disposed within an implantable controller and in communication with the implantable blood pump, and with transcutaneous energy transfer system (TETS) power in communication with the implantable blood pump, if TETS power is available.

### Claim 2 (depends on 1)

The method of claim 1, further including operating the implantable blood pump with only TETS power if:
a set speed of the implantable blood pump is able to be maintained by TETS power alone and an internal battery capacity is greater than a predetermined reserve threshold.

### Claim 3 (depends on 1)

The method of claim 1, further including operating the implantable blood pump with only TETS power if:
a minimum speed of the implantable blood pump is able to be maintained by TETS power alone and an internal battery capacity is less than a predetermined reserve threshold.

### Claim 4 (depends on 1)

The method of claim 1, further including operating the implantable blood pump with only TETS power if power from the internal battery is unavailable.

### Claim 5 (depends on 1)

The method of claim 1, further including operating the implantable blood pump only with power from the internal battery if TETS power is unavailable.

### Claim 6 (depends on 1)

The method of claim 1, further including operating the implantable blood pump only with power from the internal battery if the Battery learning cycle is required and all the prerequisites for a battery learning cycle are met.

### Claim 7

A method of managing multiple power sources for an implantable blood pump, comprising:
operating the implantable blood pump with both power from an internal battery, the internal battery being disposed within an implantable controller and in communication with the implantable blood pump, and with transcutaneous energy transfer system (TETS) power in communication with the implantable blood pump, if during operation of the implantable blood pump:
a minimum speed of the implantable blood pump is unable to be maintained by TETS power alone and an internal battery capacity is less than a predetermined reserve threshold; or
a set speed of the implantable blood pump is unable to be maintained by TETS power alone and an internal battery capacity is greater than a predetermined reserve threshold.

### Claim 8 (depends on 7)

The method of claim 7, further including operating the implantable blood pump with only TETS power if power from the internal battery is unavailable.

### Claim 9 (depends on 7)

The method of claim 7, further including operating the implantable blood pump only with power from the internal battery if TETS power is unavailable.

### Claim 10 (depends on 7)

The method of claim 7, further including operating the implantable blood pump only with power from the internal battery if the battery learning cycle is required and all the prerequisites for a battery learning cycle are met.

### Claim 11

A control circuit for an implantable blood pump, comprising:
processing circuitry configured to:
operate the implantable blood pump with both power from an internal battery, the internal battery being disposed within an implantable controller and in communication with the implantable blood pump, and with transcutaneous energy transfer system (TETS) power in communication with the implantable blood pump, if TETS power is available and if battery operation is not required.

### Claim 12 (depends on 11)

The control circuit of claim 11, wherein the processing circuitry is further configured to operate the implantable blood pump with only TETS power if:
a set speed of the implantable blood pump is able to be maintained by TETS power alone and an internal battery capacity is greater than a predetermined reserve threshold.

### Claim 13 (depends on 11)

The control circuit of claim 11, wherein the processing circuitry is further configured to operate the implantable blood pump with only TETS power if:
a minimum speed of the implantable blood pump is able to be maintained by TETS power alone and an internal battery capacity is less than a predetermined reserve threshold.

### Claim 14 (depends on 11)

The control circuit of claim 11, wherein the processing circuitry is further configured to operate the implantable blood pump with only TETS power if power from the internal battery is unavailable.

### Claim 15 (depends on 1)

The control circuit of claim 1, wherein the processing circuitry is further configured to operate the implantable blood pump only with power from the internal battery if TETS power is unavailable.

### Claim 16 (depends on 1)

The control circuit of claim 1, wherein the processing circuitry is further configured to operate the implantable blood pump only with power from the internal battery if the battery learning cycle is required and all the prerequisites for the battery learning cycle are met.

### Claim 17

A control circuit for an implantable blood pump, comprising:
processing circuitry configured to:
operate the implantable blood pump with both power from an internal battery, the internal battery being disposed within an implantable controller and in communication with the implantable blood pump, and with transcutaneous energy transfer system (TETS) power in communication with the implantable blood pump, if during operation of the implantable blood pump:
a minimum speed of the implantable blood pump is unable to be maintained by TETS power alone and an internal battery capacity is less than a predetermined reserve threshold; or
a set speed of the implantable blood pump is unable to be maintained by TETS power alone and an internal battery capacity is greater than a predetermined reserve threshold.

### Claim 18 (depends on 17)

The control circuit of claim 17, wherein the processing circuitry is further configured to operate the implantable blood pump with only TETS power if power from the internal battery is unavailable.

### Claim 19 (depends on 17)

The control circuit of claim 17, wherein the processing circuitry is further configured to operate the implantable blood pump only with power from the internal battery if TETS power is unavailable.

### Claim 20 (depends on 17)

The control circuit of claim 17, wherein the processing circuitry is further configured to operate the implantable blood pump only with power from the internal battery if the battery learning cycle is required and all the prerequisites for a battery learning cycle are met.
